India to Australia: Meloxicam Export Trade Route

The India to Australia Meloxicam corridor is one of India's established pharmaceutical export routes, with 255 shipments documented worth a combined $3.1M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 21% of all export value, reflecting the consolidated nature of India's meloxicam manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $12.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 34.4%, placing it at rank #2 among India's top meloxicam export destinations globally.

On the import side, key buyers of Indian meloxicam in Australia include GENERIC PARTNERS PTY LTD , SANDOZ PTY LTD, , GENERIC PARTNERS PTY LTD and 27 others. GENERIC PARTNERS PTY LTD is the single largest importer with 14 shipments valued at $526.9K USD.

India's meloxicam exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 92 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, GRACURE PHARMACEUTICALS LIMITED , CIPLA LIMITED — together account for 58% of total trade value on this route. The average shipment value of $12.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as meloxicam sandoz 15 mg tablet. (inv.qty and meloxicam sandoz 7.5 mg tablet (meloxica , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, GENERIC PARTNERS PTY LTD is the largest importer with 14 shipments worth $526.9K USD — representing 17% of all meloxicam imports from India on this route. A total of 30 buyers are active on this corridor.